RAYMOND JAMES & ASSOCIATES - APTOSE BIOSCIENCES INC ownership

APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 69 filers reported holding APTOSE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of APTOSE BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$23,736
+15.0%
37,087
+4.2%
0.00%
Q4 2022$20,640
+194.9%
35,587
+184.7%
0.00%
Q3 2022$7,000
-22.2%
12,5000.0%0.00%
Q2 2022$9,000
-47.1%
12,5000.0%0.00%
Q1 2022$17,000
-22.7%
12,500
-22.6%
0.00%
Q4 2021$22,000
-50.0%
16,150
-19.9%
0.00%
Q3 2021$44,000
-52.2%
20,150
-27.1%
0.00%
Q2 2021$92,000
-44.2%
27,6500.0%0.00%
Q1 2021$165,000
+25.0%
27,650
-8.0%
0.00%
Q4 2020$132,000
-26.7%
30,0500.0%0.00%
Q3 2020$180,000
+9.8%
30,050
+15.4%
0.00%
Q2 2020$164,000
-3.0%
26,050
-8.3%
0.00%
Q1 2020$169,000
+24.3%
28,400
+18.3%
0.00%
Q4 2019$136,00024,0000.00%
Other shareholders
APTOSE BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 565,000$768,0000.80%
SANDERS MORRIS HARRIS LLC 2,342,694$3,186,0000.62%
Nantahala Capital Management 7,322,189$9,958,0000.44%
DRW Securities, LLC 8,892,437$12,094,0000.33%
PRECEPT MANAGEMENT LLC 227,000$309,0000.33%
Voss Capital, LLC 550,000$748,0000.24%
CARLSON CAPITAL L P 1,564,700$2,128,0000.15%
Annandale Capital, LLC 200,000$272,0000.11%
Sigma Planning Corp 791,274$1,076,0000.03%
WealthShield Partners, LLC 104,920$143,0000.02%
View complete list of APTOSE BIOSCIENCES INC shareholders